Ursodeoxycholic acid and histological progression in primary biliary cirrhosis

By Chan C.-W.   V. Papatheodoridis G.   Goulis J.   K. Burroughs A.  

Journal of Hepatology, Vol. 39, Iss. 6, 2003-12 ,pp. : 1094-1095

Elsevier

Access to resources Recommend Favorite

Treatment of Primary Biliary Cirrhosis with Ursodeoxycholic Acid, Budesonide and Fibrates

By  

Digestive Diseases, Vol. 29, Iss. 1, 2011-06 ,pp. : 85-88

Karger

Access to resources Recommend Favorite

Pentoxifylline, but not ursodeoxycholic acid or tauroursodeoxycholic acid inhibits the proliferative effect of sera samples from primary biliary cirrhosis patients

By Peterson T.C.   Huet P.-M.  

International Hepatology Communications, Vol. 7, Iss. 2, 1997-06 ,pp. : 94-104

Elsevier

Access to resources Recommend Favorite

Methotrexate in Patients with Primary Biliary Cirrhosis Who Respond Incompletely to Treatment With Ursodeoxycholic Acid

By Kaplan Marshall   Bonder Alan   Ruthazer Robin   Bonis Peter  

Digestive Diseases and Sciences, Vol. 55, Iss. 11, 2010-11 ,pp. : 3207-3217

Springer Publishing Company

Access to resources Recommend Favorite

Therapy of Primary Biliary Cirrhosis: Novel Approaches for Patients with Suboptimal Response to Ursodeoxycholic Acid

By  

Digestive Diseases, Vol. 33, Iss. 2, 2015-0 ,pp. : 125-133

Karger

Access to resources Recommend Favorite